[HTML][HTML] CCL5/CCR5 axis in human diseases and related treatments

Z Zeng, T Lan, Y Wei, X Wei - Genes & diseases, 2022 - Elsevier
To defense harmful stimuli or maintain the immune homeostasis, the body produces and
recruits a superfamily of cytokines such as interleukins, interferons, chemokines etc. Among …

Targeting CCL5 in inflammation

RE Marques, R Guabiraba, RC Russo… - Expert opinion on …, 2013 - Taylor & Francis
Introduction: Chemokines play important roles in inflammation and in immune responses.
This article will discuss the current literature on the C–C chemokine ligand 5 (CCL5), and …

Clinical and immunological factors that distinguish COVID-19 from pandemic influenza A (H1N1)

JA Choreño-Parra, LA Jimenez-Alvarez… - Frontiers in …, 2021 - frontiersin.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), is a global health threat with the potential to cause …

Zika virus-induction of the suppressor of cytokine signaling 1/3 contributes to the modulation of viral replication

RK Seong, JK Lee, OS Shin - Pathogens, 2020 - mdpi.com
Zika virus (ZIKV) is a mosquito-borne flavivirus that has emerged and caused global
outbreaks since 2007. Although ZIKV proteins have been shown to suppress early anti-viral …

Suppressor of cytokine signaling 4 (SOCS4) protects against severe cytokine storm and enhances viral clearance during influenza infection

L Kedzierski, EM Linossi, TB Kolesnik, EB Day… - PLoS …, 2014 - journals.plos.org
Suppressor of cytokine signaling (SOCS) proteins are key regulators of innate and adaptive
immunity. There is no described biological role for SOCS4, despite broad expression in the …

Galectins regulate the inflammatory response in airway epithelial cells exposed to microbial neuraminidase by modulating the expression of SOCS1 and RIG1

M Nita-Lazar, A Banerjee, C Feng, GR Vasta - Molecular immunology, 2015 - Elsevier
Influenza patients frequently display increased susceptibility to Streptococcus pneumoniae
co-infection and sepsis, the prevalent cause of mortality during influenza pandemics …

Differential Leukocyte Expression of IFITM1 and IFITM3 in Patients with Severe Pandemic Influenza A(H1N1) and COVID-19

NE Regino-Zamarripa, G Ramírez-Martínez… - Journal of Interferon & …, 2022 - liebertpub.com
Interferon-induced transmembrane (IFITM) proteins mediate protection against enveloped
viruses by blocking membrane fusion at endosomes. IFITM1 and IFITM3 are crucial for …

[HTML][HTML] Antimicrobial peptides alter early immune response to influenza A virus infection in C57BL/6 mice

KS LeMessurier, Y Lin, JA McCullers… - Antiviral research, 2016 - Elsevier
Influenza is a disease of the respiratory system caused by single stranded RNA viruses with
varying genotypes. Immunopathogenesis to influenza viruses differs based on virus strain …

Circulating levels of miR-150 are associated with poorer outcomes of A/H1N1 infection

J Morán, G Ramírez-Martínez… - Experimental and …, 2015 - Elsevier
Background Overproduction of pro-inflammatory cytokines and chemokines is frequently
associated with severe clinical manifestations in patients infected with influenza A/H1N1 …

CXCL17 is a specific diagnostic biomarker for severe pandemic influenza A (H1N1) that predicts poor clinical outcome

JA Choreño-Parra, LA Jiménez-Álvarez… - Frontiers in …, 2021 - frontiersin.org
The CXC motif chemokine ligand 17 (CXCL17) is chemotactic for myeloid cells, exhibits
bactericidal activity, and exerts anti-viral functions. This chemokine is constitutively …